Chemomab Therapeutics's total assets for Q4 2024 were $16.96M, a decrease of -18.82% from the previous quarter. CMMB total liabilities were $3.43M for the fiscal quarter, a -25.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.